ESC Premium Access

Apixaban vs conventional therapy in anticoagulation-naive patients with atrial fibrillation undergoing cardioversion: The EMANATE Trial.

Congress Presentation

About the speaker

Professor Michael Ezekowitz

Thomas Jefferson University Hospital, Philadelphia (United States of America)
4 presentations
0 follower

Access the full session

Meet the Trialists - EMANATE

Speakers: Professor M. Ezekowitz

About the event


ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb